153 related articles for article (PubMed ID: 24084718)
1. BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas.
Zhao Y; Gou WF; Chen S; Takano Y; Xiu YL; Zheng HC
Int J Mol Sci; 2013 Sep; 14(10):19670-80. PubMed ID: 24084718
[TBL] [Abstract][Full Text] [Related]
2. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
3. The role of EMMPRIN expression in ovarian epithelial carcinomas.
Zhao Y; Chen S; Gou WF; Niu ZF; Zhao S; Xiao LJ; Takano Y; Zheng HC
Cell Cycle; 2013 Sep; 12(17):2899-913. PubMed ID: 23966157
[TBL] [Abstract][Full Text] [Related]
4. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
6. BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
Sheng SH; Zhao CM; Sun GG
Tumour Biol; 2014 Apr; 35(4):3317-26. PubMed ID: 24272202
[TBL] [Abstract][Full Text] [Related]
7. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
8. The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis.
Sun GG; Wang YD; Cheng YJ; Hu WN
Mol Biol Rep; 2014 Sep; 41(9):5979-88. PubMed ID: 24985971
[TBL] [Abstract][Full Text] [Related]
9. BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.
Zhao S; Chen SR; Yang XF; Shen DF; Takano Y; Su RJ; Zheng HC
Oncotarget; 2017 Jan; 8(5):7502-7520. PubMed ID: 27447746
[TBL] [Abstract][Full Text] [Related]
10. The treatment effects and the underlying mechanism of B cell translocation gene 1 on the oncogenesis of brain glioma.
Qian Y; Lu X; Li Q; Zhao S; Fang D
J Cell Biochem; 2019 Aug; 120(8):13310-13320. PubMed ID: 30916818
[TBL] [Abstract][Full Text] [Related]
11. The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma.
Chen S; Gou WF; Zhao S; Niu ZF; Zhao Y; Takano Y; Zheng HC
BMC Cancer; 2015 Jun; 15():471. PubMed ID: 26077911
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
[TBL] [Abstract][Full Text] [Related]
13. The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy.
Shen DF; Liu X; Yang XF; Fang L; Gao Y; Zhao S; Wu JC; Shi S; Li JJ; Zhao XX; Gou WF; Zheng HC
Tumour Biol; 2016 Mar; 37(3):2909-24. PubMed ID: 26409451
[TBL] [Abstract][Full Text] [Related]
14. BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker.
Lu YF; Sun GG; Liu Q; Yang CR; Cheng YJ
Int J Oncol; 2014 Oct; 45(4):1574-82. PubMed ID: 25017022
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of low expression of B-cell translocation gene 1 (
Li G; Yue Y; Li W; Chen Y; Fan H; Yuan J; Chen Z; Liu J
J Biosci; 2020; 45():. PubMed ID: 32457282
[TBL] [Abstract][Full Text] [Related]
16. The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma.
Chen S; Wang J; Gou WF; Xiu YL; Zheng HC; Zong ZH; Takano Y; Zhao Y
Int J Mol Sci; 2013 Dec; 14(12):24187-99. PubMed ID: 24351810
[TBL] [Abstract][Full Text] [Related]
17. B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.
Li W; Zou ST; Zhu R; Wan JM; Xu Y; Wu HR
Mol Med Rep; 2014 Jun; 9(6):2374-80. PubMed ID: 24714932
[TBL] [Abstract][Full Text] [Related]
18. Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.
Sun GG; Lu YF; Cheng YJ; Yang CR; Liu Q; Jing SW; Han XC
Tumour Biol; 2014 Dec; 35(12):11771-9. PubMed ID: 25173640
[TBL] [Abstract][Full Text] [Related]
19. B cell translocation gene 1 reduces the biological outcome of kidney cancer through induction of cell proliferation, cell cycle arrest, cell apoptosis and cell metastasis.
Sun G; Liu Q; Cheng Y; Hu W
Int J Mol Med; 2015 Mar; 35(3):777-83. PubMed ID: 25571854
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
Miao Y; Lu M; Yan Q; Li S; Feng Y
Oncol Res; 2016 Oct; 24(6):463-475. PubMed ID: 28281967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
